That DPP4 inhibition is a feasible treatment modality for the improvement of MNC homing is strengthened by the observation that in DPP4 deficient mice the mobilization capacity of the progenitor cell population was restored after myocardial infarction, and angiogenesis improved (Zaruba et al., 2009). This evidence concerns the gene DPP4 and myocardial infarction.